| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/10/2015 | CA2692612C Purification of pegylated polypeptides |
| 02/10/2015 | CA2672886C Transport molecules using reverse sequence hiv-tat polypeptides |
| 02/10/2015 | CA2669162C Novel amides acting on the adenosine receptors |
| 02/10/2015 | CA2632331C Molecules with a beta-aggregating region and their use in inducing protein aggregation |
| 02/10/2015 | CA2523363C Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| 02/10/2015 | CA2489860C Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions |
| 02/05/2015 | WO2015017861A1 Methods and compositions for the prevention and treatment of friedreich's ataxia |
| 02/05/2015 | WO2015017781A1 Methods and compositions for preventing or treating leber's hereditary optic neuropathy |
| 02/05/2015 | WO2015017715A1 Drug delivery method |
| 02/05/2015 | WO2015017642A1 Compositions and methods to treat the bihormonal disorder in diabetes |
| 02/05/2015 | WO2015017455A1 Cgrp agonist peptides |
| 02/05/2015 | WO2015017424A1 Transducible materials for cell reprogramming |
| 02/05/2015 | WO2015017316A2 Methods and compositions for modifying mucous membranes |
| 02/05/2015 | WO2015017132A1 Methods of reducing salmonella in poultry |
| 02/05/2015 | WO2015017123A1 Ghrelin splice variant for treating neuronal damage,neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression |
| 02/05/2015 | WO2015017073A1 Nutritional compositions for enhancing brain development |
| 02/05/2015 | WO2015016616A1 Saxatilin-fc fusion protein and use thereof |
| 02/05/2015 | WO2015015818A1 Composition for ameliorating metabolic disorders caused by diabetes |
| 02/05/2015 | WO2015015490A1 Trophoblast derived microparticles for treating ischemic tissue and wounds |
| 02/05/2015 | WO2015014938A1 Glycosylated protein of an extra-cellular matrix for use in a method of treating an ischemic heart of a human or animal subject in need thereof |
| 02/05/2015 | WO2015014888A1 Biocatalytical composition |
| 02/05/2015 | WO2015014830A1 Lipopetides for use in treating liver diseases and cardiovascular diseases |
| 02/05/2015 | WO2015014653A1 Aqueous sustained release compositions of lhrh analogues |
| 02/05/2015 | WO2015014228A1 Glp-1 analog fusion protein and preparation method and use thereof |
| 02/05/2015 | WO2015013932A1 Nutritional composition for inhibiting growth of tumor |
| 02/05/2015 | US20150038686 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites |
| 02/05/2015 | US20150038684 Bispecific chimeric antigen receptors and therapeutic uses thereof |
| 02/05/2015 | US20150038674 Use of glp-2 analogues in pulmonary diseases for therapeutic purpose |
| 02/05/2015 | US20150038559 Pharmaceutical Composition and Method for the Treatment of Neurodegenerative Diseases, in Particular Amyotrophic Lateral Sclerosis |
| 02/05/2015 | US20150038557 Methods and compositions for treatment of retinal degenerative diseases |
| 02/05/2015 | US20150038433 Clusterin Pharmaceuticals and Treatment Methods Using the Same |
| 02/05/2015 | US20150038432 Compositions and methods for the treatment of retinal degeneration |
| 02/05/2015 | US20150038431 Inflammatory eye disorders |
| 02/05/2015 | US20150038430 Therapeutic peptidomimetic macrocycles |
| 02/05/2015 | US20150038428 Organogels and emulsions for biological and non-biological applications |
| 02/05/2015 | US20150038423 Delivery of therapeutic agents by a collagen binding protein |
| 02/05/2015 | US20150038422 Unit dosage forms of pharmaceutical compositions comprising a polymer-factor viii polypeptide conjugate |
| 02/05/2015 | US20150038420 Methods for treating properdin-related diseases or disorders |
| 02/05/2015 | US20150038417 GLP-1 Agonists |
| 02/05/2015 | US20150038416 Novel glp-1 receptor modulators |
| 02/05/2015 | US20150038415 Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent |
| 02/05/2015 | US20150038414 Organic Compounds |
| 02/05/2015 | US20150038412 Enhanced glycemic control using ad36e4orf1 and akt1 inhibitor |
| 02/05/2015 | US20150038411 Relaxin for treating patients afflicted of impaired glucose tolerance |
| 02/05/2015 | US20150038410 Heterocyclic Nitrogen Containing Polymer Coated Analyte Monitoring Device and Methods of Use |
| 02/05/2015 | US20150038409 Leptin Compositions and Methods for Treating Progressive Cognitive Function Disorders Resulting from Accumulation of Neurofibrillary Tangles and Amyloid Beta |
| 02/05/2015 | US20150038407 Oligopeptide compounds and uses thereof |
| 02/05/2015 | US20150038406 Pharmaceutical formulations of tranexamic acid and their use |
| 02/05/2015 | US20150038404 Macrocyclic compounds |
| 02/05/2015 | US20150038403 Compounds That Bind to the Erythropoietin Receptor |
| 02/05/2015 | US20150037432 Self-assembly of collagen fibers from dermis, fascia and tendon for tissue augmentation and coverage of wounds and burns |
| 02/05/2015 | US20150037430 Formulation of a blood composition that is rich in platelet and/or growth factors and contains gelled proteins, and a method for its preparation |
| 02/05/2015 | US20150037429 Controlled Release Microparticles |
| 02/05/2015 | US20150037420 Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers |
| 02/05/2015 | US20150037402 Methods and Compositions for Treating Gastric Disorders |
| 02/05/2015 | US20150037386 Compositions and methods for promoting bone formation |
| 02/05/2015 | US20150037382 Microsphere skin treatment |
| 02/05/2015 | US20150037376 Methods and compositions for oral administration of melanocortin receptor agonist compounds |
| 02/05/2015 | US20150037359 Xten conjugate compositions and methods of making same |
| 02/05/2015 | US20150037350 Negative modulator of hedgehog signalling for use in treating th2-mediated diseases |
| 02/05/2015 | US20150037342 Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin |
| 02/05/2015 | US20150037335 Therapeutic use of p75ntr neurotrophin binding protein |
| 02/05/2015 | US20150037333 Tumour necrosis factor receptor fusion proteins and methods of using the same |
| 02/05/2015 | US20150037329 Method of reducing titers of antibodies specific for a therapeutic agent |
| 02/05/2015 | US20150037325 Slit-robo signaling for diagnosis and treatment of kidney disease |
| 02/05/2015 | US20150037315 Dietary supplement |
| 02/05/2015 | US20150037313 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| 02/05/2015 | US20150037312 Binding Proteins To The Constant Region Of Immunoglobulin G |
| 02/05/2015 | US20150037311 Targeted lysosomal enzyme compounds |
| 02/05/2015 | US20150037303 Cells, compositions, and treatment methods for stimulation of hematopoiesis |
| 02/05/2015 | US20150037301 Recombinant factor viii having enhanced stability following mutation at the a1-c2 domain interface |
| 02/05/2015 | US20150037300 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/05/2015 | US20150037296 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 02/05/2015 | US20150037291 Compositions and methods for cell transplantation |
| 02/05/2015 | US20150037287 Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same |
| 02/05/2015 | US20150037281 Variants of prothymosin alpha and methods of using same |
| 02/05/2015 | US20150037279 Sustained release formulation of interleukin-10 for wound treatment and related methods |
| 02/05/2015 | US20150037278 Initial relative lymphocyte count as predictive biomarker |
| 02/05/2015 | US20150037277 Methods of reducing salmonella in poultry |
| 02/05/2015 | US20150037249 Uses of porous nanostructure in delivery |
| 02/04/2015 | EP2832745A1 High purity cyclopeptide compound as well as preparation method and use thereof |
| 02/04/2015 | EP2832744A1 Hydrate of cyclopeptide compound as well as preparation method and use thereof |
| 02/04/2015 | EP2832743A1 High-purity cyclopeptide crystal as well as preparation method and use thereof |
| 02/04/2015 | EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis |
| 02/04/2015 | EP2832364A1 Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor XIa concentrate |
| 02/04/2015 | EP2832363A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof |
| 02/04/2015 | EP2832362A1 glycosylated protein of an extra-cellular matrix for use in a method of treating an ischemic heart of a human or animal subject in need thereof |
| 02/04/2015 | EP2832361A1 Aqueous sustained release compositions of LHRH analogs |
| 02/04/2015 | EP2832352A1 Capsule disintegrable in large-intestine-specific manner |
| 02/04/2015 | EP2831280A1 Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis |
| 02/04/2015 | EP2831228A1 Fviia-stf complexes exhibiting exosite-mediated super activity |
| 02/04/2015 | EP2831108A1 Immunomodulating cyclic compounds from the bc loop of human pd1 |
| 02/04/2015 | EP2831103A1 Anti-tumor properties of dickkopf 3b |
| 02/04/2015 | EP2831093A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis |
| 02/04/2015 | EP2830650A1 Basal insulin therapy |
| 02/04/2015 | EP2830649A1 A liquid formulation of highly concentrated long-acting human growth hormone conjugate |
| 02/04/2015 | EP2830648A1 Methods for treating neoplasia |
| 02/04/2015 | EP2830647A1 Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles |
| 02/04/2015 | EP2830646A1 Compositions and methods of use for treating metabolic disorders |
| 02/04/2015 | EP2830645A1 Use of neuregulin to treat peripheral nerve injury |